ImmunityBio and NantKwest Begin Dosing Participants in Global Trials for Novel COVID-19 Vaccine; Subcutaneous Route in South Africa, Oral and Sublingual in the U.S. One vaccine, three routes for ...

One vaccine, three routes for activating the entire immune system and providing T cell, B cell memory, and mucosal protection The first COVID-19 vaccine trials designed to deliver both S and N ...

In patients with inborn errors of immunity who are prone to viral infections, immunoglobulin replacement therapy (IRT) administered via the conventional subcutaneous route showed lower viral infection ...